Fecal Microbiota Transplantation for Primary Clostridium difficile Infection

N Engl J Med. 2018 Jun 28;378(26):2535-2536. doi: 10.1056/NEJMc1803103. Epub 2018 Jun 2.

Authors

Affiliations

¹ Oslo University Hospital, Oslo, Norway.
² University of Oslo, Oslo, Norway michael.bretthauer@medisin.uio.no.
³ Telemark Hospital, Skien, Norway.
⁴ Rigshospitalet, Copenhagen, Denmark.
⁵ Sørlandet Hospital, Kristiansand, Norway.
⁶ Vestre Viken Bærum Hospital, Gjettum, Norway.
⁷ Vestfold Hospital, Tønsberg, Norway.
⁸ Beth Israel Deaconess Medical Center, Boston, MA.
⁹ Karolinska Institutet, Stockholm, Sweden.
¹⁰ Lovisenberg Diaconal Hospital, Oslo, Norway.
¹¹ University of Oslo, Oslo, Norway.

PMID: 29860912
DOI: 10.1056/NEJMc1803103

No abstract available

Publication types

Comparative Study
Letter
Multicenter Study
Randomized Controlled Trial

MeSH terms

Anti-Infective Agents / therapeutic use*
Clostridioides difficile
Clostridium Infections / drug therapy
Clostridium Infections / therapy*
Fecal Microbiota Transplantation*
Feces / microbiology
Humans
Metronidazole / therapeutic use*
Recurrence
Treatment Outcome

Substances

Anti-Infective Agents
Metronidazole